Cited by 531Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes

Ginsberg, Henry N., Zhang, Yuan-Li, Hernandez-Ono, Antonio·2005·Archives of Medical Research

DOI 10.1016/j.arcmed.2005.01.005

Open this paper in CoChat — free account

Abstract

Increased plasma levels of triglycerides (TG) in very low density lipoproteins (VLDL) are not only common characteristics of the dyslipidemia associated with insulin resistance and type 2 diabetes mellitus (T2DM) but are the central pathophysiologic feature of the abnormal lipid profile. Overproduction of VLDL leads to increased plasma levels of TG which, via an exchange process mediated by cholesterol ester transfer protein (CETP), results in low levels of high density lipoprotein (HDL) cholesterol and apolipoprotein A-I, and the generation of small, dense, cholesterol ester depleted low density lipoproteins (LDL). Increased assembly and secretion of VLDL by the liver results from the complex, post-transcriptional regulation of apolipoprotein B (apoB) metabolism in the liver. In the presence of low levels of hepatic TG and cholesterol, much of the constitutively synthesized apoB is degraded by both proteasomal and non-proteasomal pathways. When excess TG, and to a lesser extent, cholesterol, are present, and in the presence of active microsomal triglycerides transfer protein, apoB is targeted for secretion. The major sources of TG in the liver: uptake of fatty acids (FA) released by lipolysis of adipose tissue TG, uptake of TGFA in VLDL and chylomicrons remnants, and hepatic de novo lipogenesis (the synthesis of FA from glucose) are all abnormally increased in insulin resistance. Treatment of the dyslipidemia in insulin resistant individuals and patients with T2DM has been successful in reducing cardiovascular disease; LDL cholesterol, TG, and HDL cholesterol are all appropriate targets for therapy when diet, exercise, and weight loss do not achieve goals.

Integrity signals

Registry

Crossref · 10.1016/j.arcmed.2005.01.005

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Self-citation
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
Decreased IRS-2 and Increased SREBP-1c Lead to Mixed Insulin Resistance and Sensitivity in Livers of Lipodystrophic and ob/ob Mice
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Steiner, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04209-4 · Cited by 849
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Steiner, G. A. (2001) · Cited by 732

Flagged first, then by citations

Show all 57 references

Research works printed but not linked: 2

Ginsberg, 1998, Lipoprotein physiology. Chapter 1
Taghibiglou, 2002, Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance, J Biol Chem, 277, 793, 10.1074/jbc.M106737200 · DOI

Sorted by citations

The Metabolic Syndrome
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
Retracted
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
Postic, C., & Girard, J. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,243
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Cusi, K. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 940
Pathophysiology of diabetic dyslipidaemia: where are we?
Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Meshkani, R., & Adeli, K. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.018 · Cited by 470
Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism
Matsumoto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27047 · Cited by 435
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418
Self-citation
The Metabolic Syndrome in Children and Adolescents: Shifting the Focus to Cardiometabolic Risk Factor Clustering
Magge, S. N., Goodman, E., Armstrong, S., ENDOCRINOLOGY, S. O., OBESITY, S. O., Daniels, S. R., Corkins, M. R., de Ferranti, S. D., Golden, N. H., Kim, J. H., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2017-1603 · Cited by 426
Metabolic Syndrome Pathophysiology and Predisposing Factors
Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2020) · International Journal of Sports Medicine · doi:10.1055/a-1263-0898 · Cited by 446
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents
Ota, T., Gayet, C., & Ginsberg, H. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32752 · Cited by 393
Self-citation
Hepatic lipid metabolism and non-alcoholic fatty liver disease
Tessari, P., Coracina, A., Cosma, A., & Tiengo, A. (2009) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.015 · Cited by 314
What is metabolic syndrome, and why are children getting it?
Weiss, R., Bremer, A. A., & Lustig, R. H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12030 · Cited by 314
Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
Targher, G., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3093 · Cited by 299
Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes
White, J., Swerdlow, D. I., Preiss, D., Fairhurst-Hunter, Z., Keating, B. J., Asselbergs, F. W., Sattar, N., Humphries, S. E., Hingorani, A. D., & Holmes, M. V. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1884 · Cited by 293
The role of the lipogenic pathway in the development of hepatic steatosis
Postic, C., & Girard, J. R. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74599-3 · Cited by 307
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice
Kamagaté, A., Qu, S., Perdomo, G., Su, D., Kim, D. H., Slusher, S., Meseck, M. L., & Dong, H. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32914 · Cited by 275
Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: Time for a critical appraisal
Accurso, A., Bernstein, R. K., Dahlqvist, A., Draznin, B., Feinman, R. D., Fine, E. J., Gleed, A., Jacobs, D. B., Larson, G., Lustig, R. H., et al. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-9 · Cited by 263
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications
Bays, H. E., Tighe, A. P., D, R. S. M., & Davidson, M. H. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.391 · Cited by 267
Dynamic lipidome alterations associated with human health, disease and ageing
Hornburg, D., Wu, S., Moqri, M., Zhou, X., Contrepois, K., Bararpour, N., Traber, G. M., Su, B., Metwally, A. A., Avina, M., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00880-1 · Cited by 272
Inverse associations between muscle mass, strength, and the metabolic syndrome
Atlantis, E. E., Martin, S., Haren, M. T., Taylor, A. W., & Wittert, G. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.027 · Cited by 259
Metabolic disturbances in non-alcoholic fatty liver disease
Byrne, C. D., Olufadi, R., Bruce, K. D., Cagampang, F. R. A., & Ahmed, M. H. (2009) · Clinical Science · doi:10.1042/cs20080253 · Cited by 258
Triglyceride–to–High-Density-Lipoprotein-Cholesterol Ratio is an Index of Heart Disease Mortality and of Incidence of Type 2 Diabetes Mellitus in Men
Vega, G. L., Barlow, C. E., Grundy, S. M., Leonard, D. S., & DeFina, L. F. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000044 · Cited by 237
ANGPTL4 in Metabolic and Cardiovascular Disease
Aryal, B. K., Price, N. L., Suárez, Y., & Fernandez-Hernando, C. F. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.010 · Cited by 239
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Tacer, K. F., & Rozman, D. (2011) · Journal of Lipids · doi:10.1155/2011/783976 · Cited by 242
Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men
Tirosh, A., Shai, I., Bitzur, R., Kochba, I., Tekes-Manova, D., Israeli, E., Shochat, T., & Rudich, A. (2008) · Diabetes Care · doi:10.2337/dc08-0825 · Cited by 226
Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction
Volek, J. S., & Feinman, R. D. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-31 · Cited by 223
Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links
Zafar, U., Khaliq, S., Ahmad, H., Manzoor, S., & Lone, K. P. (2018) · HORMONES · doi:10.1007/s42000-018-0051-3 · Cited by 230
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol
Love-Gregory, L. D., Sherva, R., Sun, L., Wasson, J., Schappe, T., Doria, A., Rao, D. C., Hunt, S. C., Klein, S., Neuman, R. J., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn060 · Cited by 211
Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance
Mulvihill, E. E., Assini, J. M., Lee, J. K., Allister, E. M., Sutherland, B. G., Koppes, J. B., Sawyez, C. G., Edwards, J. Y., Telford, D. E., Charbonneau, A., et al. (2011) · Diabetes · doi:10.2337/db10-0589 · Cited by 202
Toward a unifying hypothesis of metabolic syndrome
Bremer, A. A., Mietus-Snyder, M., & Lustig, R. H. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2912 · Cited by 186
Muscle-Derived Angiopoietin-Like Protein 4 Is Induced by Fatty Acids via Peroxisome Proliferator–Activated Receptor (PPAR)-δ and Is of Metabolic Relevance in Humans
Staiger, H., Haas, C., Machann, J., Werner, R., Weisser, M., Schick, F., Machicao, F., Stefan, N., Fritsche, A., & Häring, H.-U. (2009) · Diabetes · doi:10.2337/db07-1438 · Cited by 183
Manipulation of starch bioaccessibility in wheat endosperm to regulate starch digestion, postprandial glycemia, insulinemia, and gut hormone responses: a randomized controlled trial in healthy ileostomy participants
Edwards, C. H., Grundy, M. M.-L., Grassby, T., Vasilopoulou, D., Frost, G. S., Butterworth, P., Berry, S. E., Sanderson, J. D., & Ellis, P. R. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.106203 · Cited by 187
Loss of TGH/Ces3 in Mice Decreases Blood Lipids, Improves Glucose Tolerance, and Increases Energy Expenditure
Wei, E., Ali, Y. B., Lyon, J. G., Wang, H., Nelson, R. C., Dolinsky, V. W., Dyck, J. R. B., Mitchell, G. A., Korbutt, G. S., & Lehner, R. S. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.005 · Cited by 177
Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver
Quesada, H., Bas-Prior, J. M. D., Reguera, D. P., Díaz, S., Fernández-Larrea, J., Pinent, M., Arola, L., Salvadó, M. J., & Bladé, C. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.136 · Cited by 170
Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
Marzio, D. D. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s993 · Cited by 169
Insulin signaling to hepatic lipid metabolism in health and disease
Leavens, K. F., & Birnbaum, M. J. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.562481 · Cited by 169
Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp
Hussein, G. M. E., Nakagawa, T., Goto, H., Shimada, Y., Matsumoto, K., Sankawa, U., & Watanabe, H. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.041 · Cited by 150
Persistent Diet-Induced Obesity in Male C57BL/6 Mice Resulting from Temporary Obesigenic Diets
Guo, J., Jou, W., Gavrilova, O., & Hall, K. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005370 · Cited by 147
Ethnomedicinal application of native remedies used against diabetes and related complications in Mauritius
Mootoosamy, A., & Mahomoodally, M. F. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.10.069 · Cited by 141
Cholesterol and cardiovascular disease in the elderly. Facts and gaps.
Félix-Redondo, F. J., Grau, M., & Fernandez-Berges, D. J. (2013) · Europe PMC (PubMed Central) · Cited by 138
Insulin resistance and steatosis in humans
Capeau, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74600-7 · Cited by 130
Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation
Qiang, L., Lin, H. V., Kim-Muller, J. Y., Welch, C. L., Gu, W., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.007 · Cited by 122
Gut-liver interaction in triglyceride-rich lipoprotein metabolism
Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 131
TAp63 Is a Master Transcriptional Regulator of Lipid and Glucose Metabolism
Su, X., Gi, Y. J., Chakravarti, D., Chan, I. L., Zhang, A., Xia, X., Tsai, K. Y., & Flores, E. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.006 · Cited by 128
Increased fat synthesis and limited apolipoprotein B cause lipid accumulation in the liver of broiler chickens exposed to chronic heat stress
Lu, Z., He, X., B., B., Zhang, L., Li, J. L., Jiang, Y., Zhou, G., & Gao, F. (2019) · Poultry Science · doi:10.3382/ps/pez056 · Cited by 124
Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance #
Su, Q., Tsai, J., Xu, E., Qiu, W., Bereczki, E., Sántha, M., & Adeli, K. (2009) · Hepatology · doi:10.1002/hep.22960 · Cited by 118
Fatty liver: Role of inflammation and fatty acid nutrition
Byrne, C. D. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.02.012 · Cited by 119
Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents
Deivanayagam, S., Mohammed, B. S., Vitola, B. E., Naguib, G., Keshen, T. H., Kirk, E. P., & Klein, S. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.2.257 · Cited by 117
Fasting Induces Hyperlipidemia in Mice Overexpressing Proprotein Convertase Subtilisin Kexin Type 9: Lack of Modulation of Very-Low-Density Lipoprotein Hepatic Output by the Low-Density Lipoprotein Receptor
Lambert, G. C., Jarnoux, A. L., Pineau, T., Pape, O., Chétiveaux, M., LABOISSE, C. L., Krempf, M., & Costet, P. (2006) · Endocrinology · doi:10.1210/en.2006-0098 · Cited by 115
The effects of Ginkgo biloba on metabolic syndrome: A review
Eisvand, F., Razavi, B. M., & Hosseinzadeh, H. (2020) · Phytotherapy Research · doi:10.1002/ptr.6646 · Cited by 109
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1
DeAngelis, A. M., Heinrich, G., Dai, T., Bowman, T. A., Patel, P. R., Lee, S. J., Hong, E., Jung, D. Y., Aßmann, A., Kulkarni, R. N., et al. (2008) · Diabetes · doi:10.2337/db08-0379 · Cited by 106
Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population
He, S., Wang, S., Chen, X., Jiang, L., Peng, Y., Li, L., Wan, L., & Cui, K. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.007 · Cited by 106
Atypical Antipsychotics Alter Cholesterol and Fatty Acid Metabolism in Vitro
Canfrán-Duque, A., Casado, M. E., Pastor, Ó., Sánchez-Wandelmer, J., de la Peña, G., Lerma, M., Mariscal, P., Bracher, F., Lasunción, M. A., & Busto, R. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m026948 · Cited by 105
Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy
Tomita, Y., Lee, D., Tsubota, K., Negishi, K., & Kurihara, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204666 · Cited by 116
Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
Stogios, N., Gdanski, A., Gerretsen, P., Chintoh, A. F., Graff-Guerrero, A., Rajji, T. K., Remington, G., Hahn, M. K., & Agarwal, S. M. (2021) · npj Schizophrenia · doi:10.1038/s41537-021-00151-6 · Cited by 98
The role of dyslipidemia in diabetic retinopathy
Hammer, S. S., & Busik, J. V. (2017) · Vision Research · doi:10.1016/j.visres.2017.04.010 · Cited by 100
Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue
Lappas, M. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.001 · Cited by 97
Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes
Vergès, B. L. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.028 · Cited by 105
Carbohydrate Restriction Alters Lipoprotein Metabolism by Modifying VLDL, LDL, and HDL Subfraction Distribution and Size in Overweight Men
Wood, R. J., Volek, J. S., Liu, Y., Shachter, N. S., Contois, J. H., & Fernández, M. L. (2006) · Journal of Nutrition · doi:10.1093/jn/136.2.384 · Cited by 96
Postdinner resistance exercise improves postprandial risk factors more effectively than predinner resistance exercise in patients with type 2 diabetes
Heden, T. D., Winn, N. C., Mari, A., Booth, F. W., Rector, R. S., Thyfault, J. P., & Kanaley, J. A. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00917.2014 · Cited by 99
Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice
Chang, B. H., Li, L., Saha, P., & Chan, L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004515 · Cited by 94
Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
Scigliano, G., & Ronchetti, G. (2013) · CNS Drugs · doi:10.1007/s40263-013-0054-1 · Cited by 92
Statistical Correlation and Projection Methods for Improved Information Recovery from Diffusion-Edited NMR Spectra of Biological Samples
Smith, L. M., Maher, A. D., Cloarec, O., Rantalainen, M., Tang, H., Elliott, P., Stamler, J., Lindon, J. C., Holmes, E. C., & Nicholson, J. K. (2007) · Analytical Chemistry · doi:10.1021/ac0703754 · Cited by 86
A Rice Bran Oil Diet Improves Lipid Abnormalities and Suppress Hyperinsulinemic Responses in Rats with Streptozotocin/Nicotinamide-Induced Type 2 Diabetes
Chou, T.-W., Ma, C.-Y., Cheng, H.-H., Chen, Y., & Lai, M.-H. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-257 · Cited by 85
Obesity in Diabetic Patients Undergoing Coronary Artery Bypass Graft Surgery Is Associated with Increased Postoperative Morbidity
Pan, W., Hindler, K., Lee, V., Vaughn, W. K., & Collard, C. D. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00010 · Cited by 83
Lipoprotein metabolism in nonalcoholic fatty liver disease
Jiang, Z. G., Simon, K. A., & Zemin, Y. (2013) · Journal of Biomedical Research · doi:10.7555/jbr.27.20120077 · Cited by 89
Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition
Eichelmann, F., Prada, M., Sellem, L., Jackson, K. G., Salas‐Salvadó, J., Razquín, C., Estruch, R., Friedén, M., Rosqvist, F., Risérus, U., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03124-1 · Cited by 92
Alterations in Hepatic Metabolism in fld Mice Reveal a Role for Lipin 1 in Regulating VLDL-Triacylglyceride Secretion
Chen, Z., Gropler, M. C., Norris, J. Y., Lawrence, J. C., Harris, T. E., & Finck, B. N. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171538 · Cited by 81
Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance
Castellani, L. W., Nguyen, C., Charugundla, S., Weinstein, M. M., Doan, C. X., Blaner, W. S., Wongsiriroj, N., & Lusis, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708995200 · Cited by 79
Lipoprotein metabolism in chronic renal insufficiency
Saland, J. M., & Ginsberg, H. N. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0467-5 · Cited by 79
Self-citation
Deficiency of 25-Hydroxyvitamin D and Dyslipidemia in Indian Subjects
Chaudhuri, J. R., Mridula, K. R., Anamika, A., Boddu, D. B., Mısra, P. K., Lingaiah, A., Balaraju, B., & Bandaru, V. S. (2013) · Journal of Lipids · doi:10.1155/2013/623420 · Cited by 79
Common Polymorphisms in the Promoter of the Visfatin Gene (PBEF1) Influence Plasma Insulin Levels in a French-Canadian Population
Bailey, S. D., Loredo‐Osti, J. C., Lepage, P., Faith, J., Fontaine, J., Desbiens, K., Hudson, T. J., Bouchard, C., Gaudet, D., Përusse, L., et al. (2006) · Diabetes · doi:10.2337/db06-0189 · Cited by 78
Sucrose feeding in mouse pregnancy leads to hypertension, and sex-linked obesity and insulin resistance in female offspring
Samuelsson, A., Matthews, P. A., Jansen, E., Taylor, P. D., & Poston, L. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00014 · Cited by 77
The effects of short-chain fatty acids on the cardiovascular system
Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J., & Folkerts, G. (2016) · PharmaNutrition · doi:10.1016/j.phanu.2016.02.001 · Cited by 77
Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia
Haeusler, R. A., Han, S., & Accili, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134023 · Cited by 72
Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes
Lauressergues, E., Staels, B., Valeille, K., Majd, Z., Hum, D. W., Duriez, P., & Cussac, D. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0499-4 · Cited by 72
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
Davidson, M. H., Maki, K. C., Bays, H., Carter, R., & Ballantyne, C. M. (2009) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2009.08.001 · Cited by 71
Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome
O’Neill, B. J. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000569 · Cited by 72
Metabolic Effects of Obesity and Its Interaction with Endocrine Diseases
Clark, M., & Hoenig, M. E. (2016) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2016.04.004 · Cited by 74
Peroxisome Proliferator-activated Receptor α Deficiency Abolishes the Response of Lipogenic Gene Expression to Re-feeding
Hebbachi, A., Knight, B. L., Wiggins, D. K., Patel, D. D., & Gibbons, G. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m709471200 · Cited by 71
Human serum/plasma lipoprotein analysis by NMR: Application to the study of diabetic dyslipidemia
Mallol, R., Rodriguez, M. A., Brezmes, J., Masana, L., & Correig, X. (2012) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2012.09.001 · Cited by 68
Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: Evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction
Dekker, M. J., Baker, C., Naples, M., Samsoondar, J. P., Zhang, R., Qiu, W., Sacco, J., & Adeli, K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.041 · Cited by 68
Estimation of Plasma Small Dense LDL Cholesterol From Classic Lipid Measures
Srisawasdi, P., Chaloeysup, S., Teerajetgul, Y., Pocathikorn, A., Sukasem, C., Vanavanan, S., & Kroll, M. H. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcplhjbgg9l3ils · Cited by 65
The Impact of Education and Age on Metabolic Disorders
Stephens, C. R., Easton, J. F., Robles-Cabrera, A., Fossión, R., de la Cruz, L., Tapia, R., Barajas‐Martínez, A., Hernández-Chávez, A. A., López-Rivera, J. A., & Rivera, A. L. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00180 · Cited by 69
Human Resistin Stimulates Hepatic Overproduction of Atherogenic ApoB-Containing Lipoprotein Particles by Enhancing ApoB Stability and Impairing Intracellular Insulin Signaling
Costandi, J., Melone, M., Zhao, A., & Rashid, S. (2011) · Circulation Research · doi:10.1161/circresaha.110.238949 · Cited by 65
Exercise and Polycystic Ovary Syndrome
Woodward, A., Klonizakis, M., & Broom, D. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_8 · Cited by 68
Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Aleksandrova, K., Jenab, M., Bueno-de-Mesquita, H. B., Fedirko, V., Kaaks, R., Lukanova, A., van Duijnhoven, F. J. B., Jansen, E. H. J. M., Rinaldi, S., Romieu, I., et al. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9901-8 · Cited by 64
Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice
Lian, J., Wei, E., Wang, S. P., Quiroga, A. D., Li, L., Pardo, A. D., van der Veen, J., Sipione, S., Mitchell, G. A., & Lehner, R. S. (2012) · Hepatology · doi:10.1002/hep.25881 · Cited by 64
Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ
Mao, H., Lockyer, P. P., Li, L., Ballantyne, C. M., Patterson, C., Xie, L., & Pi, X. (2017) · Nature Communications · doi:10.1038/ncomms14960 · Cited by 63
Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children
Rodríguez‐Rodríguez, E., Anta, R. M. O., González‐Rodríguez, L. G., & López-Sobaler, A. M. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0145-4 · Cited by 60
An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations
Mameli, C., Zuccotti, G., Carnovale, C., Galli, E., Nannini, P., Cervia, D., & Perrotta, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.017 · Cited by 63
Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment
Chung, L. Y., & Rhie, Y. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes21063 · Cited by 67
Adipokines and Redox Signaling: Impact on Fatty Liver Disease
Parola, M., & Marra, F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3848 · Cited by 60
Overweight and obesity: The pathogenesis of cardiometabolic risk
Bray, G. A., Clearfield, M. B., Fintel, D. J., & Nelinson, D. S. (2009) · Clinical cornerstone · doi:10.1016/s1098-3597(09)80003-3 · Cited by 61
Inactivity induces resistance to the metabolic benefits following acute exercise
Akins, J. D., Crawford, C. K., Burton, H. M., Wolfe, A. S., Vardarli, E., & Coyle, E. F. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00968.2018 · Cited by 59
The effects of a Melissa officinalis L. based product on metabolic parameters in patients with type 2 diabetes mellitus: A randomized double-blinded controlled clinical trial
Nayebi, N., Esteghamati, A., Meysamie, A., Khalili, N., Kamalinejad, M., Emtiazy, M., & Hashempur, M. H. (2019) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2018-0088 · Cited by 57
Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus
Ellerbrock, J., Spaanderman, B., van Drongelen, J., Mulder, E., van Balen, V. A. L., Schiffer, V. M. M. M., Jorissen, L. M., Alers, R., Leenen, J., Ghossein‐Doha, C., et al. (2022) · Nutrients · doi:10.3390/nu14122444 · Cited by 68
Cardiometabolic Risk and Body Composition in Youth With Down Syndrome
Magge, S. N., Zemel, B. S., Pipan, M. E., Gidding, S. S., & Kelly, A. T. (2019) · PEDIATRICS · doi:10.1542/peds.2019-0137 · Cited by 60
Glycine Normalizes Hepatic Triglyceride-Rich VLDL Secretion by Triggering the CNS in High-Fat Fed Rats
Yue, J. T. Y., Mighiu, P. I., Naples, M., Adeli, K., & Lam, T. K. T. (2012) · Circulation Research · doi:10.1161/circresaha.112.268276 · Cited by 56

Authors: Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A.
Affiliations: Columbia University (US)
Corresponding author: Ginsberg, Henry N.
ORCID: Ginsberg, Henry N.
Venue: Archives of Medical Research
Publisher: Elsevier BV
Published: 2005-05
Volume: 36
Issue: 3
Pages: 232-240
ISSN: 0066-6769 (ISSN-L)
0188-4409
DOI: 10.1016/j.arcmed.2005.01.005
OpenAlex: W2095612977
Cited by: 531
References: 57
Citations by year: 2026: 11 · 2025: 19 · 2024: 24 · 2023: 27 · 2022: 26 · 2021: 27 · 2020: 34 · 2019: 24 · 2018: 25 · 2017: 27 · 2016: 33 · 2015: 31 · 2014: 20 · 2013: 28 · 2012: 24
FWCI: 4.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Archives of Medical Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: plasma triglycerides, insulin resistance, type 2 diabetes, dyslipidemia, VLDL secretion, apolipoprotein B, hepatic triglyceride metabolism, cholesteryl ester transfer protein, HDL cholesterol, small dense LDL, microsomal triglyceride transfer protein, hepatic de novo lipogenesis, lipolysis, cardiovascular disease, lipid-lowering therapy
MeSH terms: Adipose Tissue, Animals, Apolipoproteins B, Cholesterol, Chylomicrons, Diabetes Mellitus, Type 2, Fatty Acids, Humans, Insulin Resistance, Lipoproteins, Lipoproteins, HDL, Lipoproteins, VLDL, Liver, Models, Biological, Triglycerides, Apolipoprotein A-I, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks